Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.
One of the current goals in vaccine development is the noninvasive administration of protective antigens via mucosal surfaces. In this context, the gut-associated lymphoid tissues have already been extensively explored. Vaccination via the nasal route has only recently been the focus of intensive in...
محفوظ في:
| الحاوية / القاعدة: | Infect Immun |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
American Society for Microbiology (ASM)
1997
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176094/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9009311/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.65.2.544-550.1997 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|